CSIMarket
 


Stryker Corp  (SYK)
Other Ticker:  
 

Cumulative Stryker's Working Capital Ratio for Trailing Twelve Months Period

SYK's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SYK Working Capital Ratio for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth 49.5 % 33.08 % 38.56 % 2.74 % 3.57 %
Y / Y Current Assets Growth 15.03 % 16.39 % 2.58 % -1.5 % -2.29 %
Working Capital Ratio for Trailing Twelve Months Period 1.71 1.82 1.89 2.06 2.08
Total Ranking # 1242 # 2060 # 2189 # 2221 # 2485
Seq. Current Liabilities Growth 12.24 % -6.93 % 37.89 % 3.79 % -0.09 %
Seq. Current Assets Growth -0.04 % -1.17 % 10.27 % 5.59 % 1.15 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Due to increase in Current Liabilities in the II. Quarter to $6,584 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 1.71 below Stryker Corp average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 101 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Stryker. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about SYK
Working Capital Ratio SYK in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 102
Sector # 377
S&P 500 # 1374


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.07 3.07 1.71
(Dec. 31. 2010)   (Dec 31 2023)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Vapotherm Inc   4.64 
Nuo Therapeutics Inc   4.50 
Glucotrack Inc   4.45 
Quoin Pharmaceuticals Ltd   4.45 
Nuwellis Inc   4.45 
Axogen inc   4.42 
Assure Holdings Corp   4.39 
Soleno Therapeutics Inc  4.33 
Establishment Labs Holdings Inc   4.25 
Nexalin Technology Inc   4.21 
Zynex inc   4.21 
Edap Tms Sa  4.17 
Irhythm Technologies Inc   4.11 
Nutriband Inc   4.11 
Movano Inc   4.10 
Milestone Scientific Inc   4.08 
Tivic Health Systems Inc   3.99 
Cutera Inc   3.95 
Catheter Precision Inc   3.89 
Insulet Corporation  3.83 
Inovio Pharmaceuticals Inc   3.61 
Atricure Inc   3.61 
Paragon 28 Inc   3.57 
West Pharmaceutical Services Inc   3.54 
Lensar Inc   3.53 
Reunion Neuroscience Inc   3.52 
Integra Lifesciences Holdings Corp  3.50 
Tenon Medical Inc   3.38 
Seaspine Holdings Corporation  3.33 
Electrocore Inc   3.33 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com